Fenoldopam Mesylate for the Prevention of Contrast-Induced Nephropathy | NobleBlocks

Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.

Public

Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.

N

Shared by NobleBlocks on Nov 5, 2003 • 12:00 AM UTC

Authors:

G. Stone

,

P. McCullough

,

J. Tumlin

Subject

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!

Publication Date: Nov 5, 2003 • 12:00 AM UTC

DOI:10.1001/JAMA.290.17.2284

No figures available

Scan for Errors

Scan for EDDII

Summarise

Generate Podcast